Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ONJCRI leads over a hundred clinical trials annually focused on immunotherapies, targeted therapies and personalised medicine for a broad range of cancers. The institute has pioneered theranostic approaches combining imaging with novel drugs for both diagnosis and treatment. Recent results include successful initiation of first-in-human radiopharmaceutical trials and improved survival rates in liver cancer patients using new treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olivia Newton-John Cancer Research Institute.